Thanks Longreach. Another thing - John McCutcheon stressed FDA approval is no longer a binary risk, meaning any risk is “temporal”. But even if FDA approval becomes delayed, JM gave me a strong impression that Runway Capital (their lenders) would back them all the way. EBR Systems will succeed! It was good to chat with JM and feel his confidence.
Ann: EBR Systems Investor Roadshow, page-15
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
85.5¢ |
Change
-0.040(4.47%) |
Mkt cap ! $311.2M | |||
| Open | High | Low | Value | Volume |
| 90.0¢ | 90.0¢ | 85.5¢ | $282.1K | 321.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 68410 | 85.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 86.5¢ | 5556 | 4 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| EBR (ASX) Chart |